DRUG POLICY ALLIANCE for DRUG POLICY ALLIANCE
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Oct 3, 2016 | $80,000 | Replaced |
| 2nd Quarter - Amendment (this page) | Jan 29, 2018 | $80,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL COLLINS | — |
| BILL J PIPER | — |
| GRANT SMITH | — |
Budget/Appropriations BUD
Issues related to marijuana legalization, syringe funding ban, overdose prevention.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL COLLINS | — |
| BILL J PIPER | — |
Law Enforcement/Crime/Criminal Justice LAW
Sentencing Reform and Corrections Act, issues relating to drug sentencing. FAIR Act, issues relating to civil asset forfeiture. Issues related to ending federal marijuana prohibition.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL COLLINS | — |
| BILL J PIPER | — |
| GRANT SMITH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.